Dr. Yousif Abubakr, MD
What this data tells you about Dr. Abubakr
Dr. Yousif Abubakr is a hematology & oncology in Jacksonville, FL, with 20 years in practice. Based on federal Medicare data, Dr. Abubakr performed 77,221 Medicare services across 2,981 unique beneficiaries.
Between the years covered by Open Payments, Dr. Abubakr received a total of $1,602 from 29 pharmaceutical and/or device companies across 54 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Abubakr is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) | 30,000 | $1 | $4 |
| Contrast dye for imaging (iodine-based) | 25,800 | $0 | $1 |
| Epoetin alfa injection (Retacrit) for anemia | 9,160 | $6 | $27 |
| Denosumab injection (Prolia/Xgeva) | 2,940 | $18 | $40 |
| MRI contrast dye injection (gadoterate) | 1,501 | $0 | $25 |
| Complete blood count (CBC) with differential | 1,279 | $8 | $41 |
| Blood draw (venipuncture) | 1,278 | $8 | $18 |
| Dexamethasone injection (steroid) | 1,082 | $0 | $1 |
| Injection, granisetron hydrochloride, 100 mcg | 540 | $0 | $41 |
| Office visit, established patient (20-29 min) | 459 | $62 | $104 |
| Drug injection, under skin or into muscle | 405 | $11 | $42 |
| Office visit, established patient (30-39 min) | 359 | $94 | $162 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 259 | $21 | $90 |
| Ct scan of chest with contrast | 217 | $50 | $500 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 208 | $1,085 | $2,400 |
| Administration of chemotherapy into vein, 1 hour or less | 195 | $98 | $355 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 192 | $393 | $1,000 |
| CT scan of abdomen and pelvis with contrast | 174 | $163 | $535 |
| Blood creatinine level | 149 | $5 | $29 |
| Infusion, normal saline solution , 1000 cc | 108 | $2 | $97 |
| Hospital follow-up visit, moderate complexity | 89 | $60 | $115 |
| Infusion into a vein for hydration, 31-60 minutes | 75 | $24 | $130 |
| Mri scan of brain before and after contrast | 74 | $124 | $560 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 62 | $46 | $160 |
| Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | 61 | $73 | $70 |
| Injection, diphenhydramine hcl, up to 50 mg | 57 | $1 | $4 |
| Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie | 55 | $814 | $2,585 |
| Gallium ga-68 gozetotide, diagnostic, (locametz), 1 millicurie | 55 | $661 | $2,200 |
| Mri scan of abdomen before and after contrast | 53 | $136 | $662 |
| Copper cu-64, dotatate, diagnostic, 1 millicurie | 52 | $1,847 | $2,524 |
| CT scan of chest, without contrast | 49 | $41 | $310 |
| Infusion into a vein for hydration, each additional hour | 49 | $10 | $40 |
| Injection of additional new drug or substance into vein | 39 | $12 | $55 |
| Initial hospital admission, moderate complexity | 34 | $100 | $225 |
| New patient office visit (45-59 min) | 33 | $123 | $265 |
| Ct scan of abdomen and pelvis without contrast | 29 | $79 | $270 |
| Nuclear medicine study whole body with ct scan | 20 | $1,089 | $2,490 |
| Ct scan of soft tissue of neck with contrast | 18 | $84 | $495 |
| Initial hospital admission, high complexity | 12 | $137 | $330 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (91%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
5.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Abubakr is a mixed practice specialist, with above-average Medicare volume (top 10% in FL), and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Abubakr experienced with iron infusion (injectafer)?
Does Dr. Abubakr receive payments from pharmaceutical companies?
How do Dr. Abubakr's costs compare to other hematology & oncologys in Jacksonville?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology